Navamedic ASA Total Liabilities
Navamedic ASA total liabilities. Based on the latest financial reports, Navamedic ASA (NAVA) has total liabilities worth Nkr350.53 Million NOK (≈ $36.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Navamedic ASA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Navamedic ASA (2003–2025)
Total liabilities of Navamedic ASA from 2003 to 2025. This chart illustrates how Navamedic ASA's total liabilities have evolved over time, based on quarterly financial data. Check NAVA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Navamedic ASA Competitors by Total Liabilities
The table below lists competitors of Navamedic ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Envirotech Vehicles Inc
NASDAQ:EVTV
|
USA | $19.37 Million |
|
Alakasa Industrindo Tbk
JK:ALKA
|
Indonesia | Rp12.86 Billion |
|
Happy Creek Minerals Ltd
V:HPY
|
Canada | CA$254.53K |
|
Oxford Nanopore Technologies Ltd
LSE:ONT
|
UK | GBX141.30 Million |
|
Sierra Nevada Gold Inc
AU:SNX
|
Australia | AU$1.22 Million |
|
TOP Ships Inc.
NASDAQ:TOPS
|
USA | $278.35 Million |
|
Estrella Immunopharma Inc.
NASDAQ:ESLA
|
USA | $9.26 Million |
|
Audacia SAS
PA:ALAUD
|
France | €11.07 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Navamedic ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Navamedic ASA total assets.
Liquidity & Leverage Metrics
Navamedic ASA Total Liabilities Ratios Explained
Navamedic ASA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Navamedic ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Navamedic ASA (2003–2025)
The table below shows the annual total liabilities of Navamedic ASA from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr407.67 Million ≈ $42.90 Million |
+62.55% |
| 2024-12-31 | Nkr250.81 Million ≈ $26.39 Million |
-16.93% |
| 2023-12-31 | Nkr301.91 Million ≈ $31.77 Million |
+74.46% |
| 2022-12-31 | Nkr173.05 Million ≈ $18.21 Million |
-3.29% |
| 2021-12-31 | Nkr178.94 Million ≈ $18.83 Million |
+37.07% |
| 2020-12-31 | Nkr130.55 Million ≈ $13.74 Million |
+21.08% |
| 2019-12-31 | Nkr107.83 Million ≈ $11.35 Million |
-6.57% |
| 2018-12-31 | Nkr115.41 Million ≈ $12.14 Million |
-23.35% |
| 2017-12-31 | Nkr150.57 Million ≈ $15.84 Million |
-17.24% |
| 2016-12-31 | Nkr181.94 Million ≈ $19.15 Million |
+15.68% |
| 2015-12-31 | Nkr157.27 Million ≈ $16.55 Million |
+54.23% |
| 2014-12-31 | Nkr101.97 Million ≈ $10.73 Million |
+41.19% |
| 2013-12-31 | Nkr72.22 Million ≈ $7.60 Million |
+94.80% |
| 2012-12-31 | Nkr37.07 Million ≈ $3.90 Million |
-19.11% |
| 2011-12-31 | Nkr45.83 Million ≈ $4.82 Million |
+98.24% |
| 2010-12-31 | Nkr23.12 Million ≈ $2.43 Million |
-6.65% |
| 2009-12-31 | Nkr24.77 Million ≈ $2.61 Million |
-49.86% |
| 2008-12-31 | Nkr49.40 Million ≈ $5.20 Million |
-12.51% |
| 2007-12-31 | Nkr56.46 Million ≈ $5.94 Million |
-768.93% |
| 2006-12-31 | Nkr-8.44 Million ≈ $-888.25K |
-275.64% |
| 2005-12-31 | Nkr4.81 Million ≈ $505.74K |
-347.21% |
| 2004-12-31 | Nkr-1.94 Million ≈ $-204.58K |
-69.81% |
| 2003-12-31 | Nkr-6.44 Million ≈ $-677.59K |
-- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more